149 related articles for article (PubMed ID: 31992853)
1. PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer.
Chauhan SS; Toth RK; Jensen CC; Casillas AL; Kashatus DF; Warfel NA
Oncogene; 2020 Mar; 39(12):2597-2611. PubMed ID: 31992853
[TBL] [Abstract][Full Text] [Related]
2. QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission.
Ding R; Wang Y; Xu L; Sang S; Wu G; Yang W; Zhang Y; Wang C; Qi A; Xie H; Liu Y; Dai A; Jiao L
J Cell Mol Med; 2024 May; 28(9):e18353. PubMed ID: 38682742
[TBL] [Abstract][Full Text] [Related]
3. Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation.
Din S; Mason M; Völkers M; Johnson B; Cottage CT; Wang Z; Joyo AY; Quijada P; Erhardt P; Magnuson NS; Konstandin MH; Sussman MA
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5969-74. PubMed ID: 23530233
[TBL] [Abstract][Full Text] [Related]
4. Pim-1 Kinase Regulating Dynamics Related Protein 1 Mediates Sevoflurane Postconditioning-induced Cardioprotection.
Liu JD; Chen HJ; Wang DL; Wang H; Deng Q
Chin Med J (Engl); 2017 Feb; 130(3):309-317. PubMed ID: 28139514
[TBL] [Abstract][Full Text] [Related]
5. Luteolin enhances TRAIL sensitivity in non-small cell lung cancer cells through increasing DR5 expression and Drp1-mediated mitochondrial fission.
Wu B; Xiong J; Zhou Y; Wu Y; Song Y; Wang N; Chen L; Zhang J
Arch Biochem Biophys; 2020 Oct; 692():108539. PubMed ID: 32777260
[TBL] [Abstract][Full Text] [Related]
6. PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.
Kim W; Youn H; Kwon T; Kang J; Kim E; Son B; Yang HJ; Jung Y; Youn B
Pharmacol Res; 2013 Apr; 70(1):90-101. PubMed ID: 23352980
[TBL] [Abstract][Full Text] [Related]
7. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.
Padi SKR; Luevano LA; An N; Pandey R; Singh N; Song JH; Aster JC; Yu XZ; Mehrotra S; Kraft AS
Oncotarget; 2017 May; 8(18):30199-30216. PubMed ID: 28415816
[TBL] [Abstract][Full Text] [Related]
8. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
9. Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway.
Deng X; Liu J; Liu L; Sun X; Huang J; Dong J
Int J Biol Sci; 2020; 16(8):1403-1416. PubMed ID: 32210728
[TBL] [Abstract][Full Text] [Related]
10. High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1.
Liu WL; Li CY; Cheng WC; Chang CY; Chen YH; Lu CY; Wang SC; Liu YR; Cheng MH; Chong IW; Liu PL
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807275
[TBL] [Abstract][Full Text] [Related]
11. Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.
Kim DI; Lee KH; Gabr AA; Choi GE; Kim JS; Ko SH; Han HJ
Biochim Biophys Acta; 2016 Nov; 1863(11):2820-2834. PubMed ID: 27599716
[TBL] [Abstract][Full Text] [Related]
12. An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications.
Dasgupta A; Chen KH; Wu D; Hoskin V; Mewburn J; Lima PDA; Parlow LRG; Hindmarch CCT; Martin A; Sykes EA; Tayade C; Lightbody ED; Madarnas Y; SenGupta SK; Elliott BE; Nicol CJB; Archer SL
FASEB J; 2020 Apr; 34(4):5106-5127. PubMed ID: 32068312
[TBL] [Abstract][Full Text] [Related]
13. PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species.
Warfel NA; Sainz AG; Song JH; Kraft AS
Mol Cancer Ther; 2016 Jul; 15(7):1637-47. PubMed ID: 27196781
[TBL] [Abstract][Full Text] [Related]
14. Cyclopamine tartrate, an inhibitor of Hedgehog signaling, strongly interferes with mitochondrial function and suppresses aerobic respiration in lung cancer cells.
Alam MM; Sohoni S; Kalainayakan SP; Garrossian M; Zhang L
BMC Cancer; 2016 Feb; 16():150. PubMed ID: 26911235
[TBL] [Abstract][Full Text] [Related]
15. AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.
Qi M; Dai D; Liu J; Li Z; Liang P; Wang Y; Cheng L; Zhan Y; An Z; Song Y; Yang Y; Yan X; Xiao H; Shao H
Oncogene; 2020 Mar; 39(13):2707-2723. PubMed ID: 32005973
[TBL] [Abstract][Full Text] [Related]
16. Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response.
Chatterjee S; Chakraborty P; Daenthanasanmak A; Iamsawat S; Andrejeva G; Luevano LA; Wolf M; Baliga U; Krieg C; Beeson CC; Mehrotra M; Hill EG; Rathmell JC; Yu XZ; Kraft AS; Mehrotra S
Clin Cancer Res; 2019 Feb; 25(3):1036-1049. PubMed ID: 30327305
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.
Romani P; Nirchio N; Arboit M; Barbieri V; Tosi A; Michielin F; Shibuya S; Benoist T; Wu D; Hindmarch CCT; Giomo M; Urciuolo A; Giamogante F; Roveri A; Chakravarty P; Montagner M; Calì T; Elvassore N; Archer SL; De Coppi P; Rosato A; Martello G; Dupont S
Nat Cell Biol; 2022 Feb; 24(2):168-180. PubMed ID: 35165418
[TBL] [Abstract][Full Text] [Related]
18. Activation of Pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors.
An N; Xiong Y; LaRue AC; Kraft AS; Cen B
Cancer Res; 2015 Dec; 75(24):5318-28. PubMed ID: 26670562
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
Song JH; Padi SK; Luevano LA; Minden MD; DeAngelo DJ; Hardiman G; Ball LE; Warfel NA; Kraft AS
Oncotarget; 2016 Apr; 7(15):20152-65. PubMed ID: 26956053
[TBL] [Abstract][Full Text] [Related]
20. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
